Oral Presentation

[31-412-pm] Intracellular signaling 3

Sun. Mar 31, 2024 1:15 PM - 2:15 PM [Room 412] Conference Center 412 (4F)

Chair: Mitsuru Okuwaki, Miho Shimizu

+Add all to schedule

1:15 PM - 1:27 PM

[31-412-pm01S] Ligand-dependent difference in canonical/non-canonical phosphorylation patterns of EGFR

○Shinya Morita¹, Maki Sato¹, Kyoko Otuyama¹, Yue Zhou¹, Satoru Yokoyama¹, Hiroaki Sakurai¹ (1. Grad.Sch.Pharm.Sci., Toyama Univ.)

1:27 PM - 1:39 PM

[31-412-pm02] SIS3 inhibits TGF-β signaling via targeting downstream processes of Smad phosphorylation

○Yuka Itoh¹, Hao Fu¹, Masao Saitoh¹, Keiji Miyazawa¹ (1. Grad. Sch. Med., Univ. of Yamanashi)

1:39 PM - 1:51 PM

[31-412-pm03S] Tric-b knockout causes atypical cell death and insufficient extracellular matrix organization in growth plates

○Hiroki Nagatomo¹, Atsuhiko Ichimura¹, Takaaki Kawabe¹, Nobuhisa Nakajima¹, Ga Eun Kim¹, Hiroshi Takeshima¹ (1. Grad. Sch. Pharm. Sci., Kyoto Univ.)

1:51 PM - 2:03 PM

[31-412-pm04S] Research on proliferative suppression and undifferentiated state of mesenchymal stem cells cultured using the functional three-dimensional biopolymer.

○Kazuki Nakazawa¹, Masashi Uchida², Masayuki Ishikawa^1,2, Shiho Anno³, Daisuke Hatanaka³, Hisato Hayashi³, Shingo Yamazaki^1,2, Takaaki Suzuki^1,2, Itsuko Ishii^1,2 (1. Grad. Sch. Pharm. Sci., Chiba Univ., 2. Division of pharmacy, Chiba Univ. Hosp., 3. Nissan Chemical Corp.)

2:03 PM - 2:15 PM

[31-412-pm05S] Development of a fluorescence HPLC-based method for analysis of KRAS activation state and its application to in vivo assay for the evaluation of the KRAS/G12C inhibitor

○Yukika Kasuya¹, Kaho Yoshimoto¹, Makoto Araki¹, Kenji Kontani¹ (1. Meiji Pharm. Univ.)

Session information